跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Govastin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Govastin
Approved
STANDARD
Govastin
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
db467baf4d382d45
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
db467baf4d382d45
Drug Approval Philippines Name
Govastin
Product Name
Govastin
Registration Number
DRP-3109-08
Brand Name
Govastin
Generic Name
Atorvastatin (as Calcium)
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Applied Pharmaceutical Distribution Inc.
Issuance Date
27 March 2024
Expiry Date
12 July 2029
Pharmacologic Category
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
db467baf4d382d45
Type
Standard
Back to Philippines FDA Approvals